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Cathepsin S is a lysosomal cysteine protease highly expressed in immune cells such as
dendritic cells, B cells and macrophages. Its functions include extracellular matrix
breakdown and cleavage of cell adhesion molecules to facilitate immune cell motility,
as well as cleavage of the invariant chain during maturation of major histocompatibility
complex II. The identification of these diverse specific functions has brought the challenge
of delineating cathepsin S activity with great spatial precision, relative to related enzymes
and substrates. Here, the development of a potent and highly selective two-step activity-
based probe for cathepsin S and the application in multicolor bio-orthogonal correlative
light-electron microscopy is presented. LHVS, which has been reported as a selective
inhibitor of cathepsin S with nanomolar potency, formed the basis for our probe design.
However, in competitive activity-based protein profiling experiments LHVS showed
significant cross-reactivity toward Cat L. Introduction of an azide group in the P2
position expanded the selectivity window for cathepsin S, but rendered the probe
undetectable, as demonstrated in bio-orthogonal competitive activity-based protein
profiling. Incorporation of an additional azide handle for click chemistry on the solvent-
exposed P1 position allowed for selective labeling of cathepsin S. This highlights the
influence of click handle positioning on probe efficacy. This probe was utilized in multicolor
bio-orthogonal confocal and correlative light-electron microscopy to investigate the
localization of cathepsin S activity at an ultrastructural level in bone marrow-derived
dendritic cells. The tools developed in this study will aid the characterization of the
variety of functions of cathepsin S throughout biology.
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INTRODUCTION
Cathepsin S (Cat S) is a lysosomal cysteine endopeptidase from
the papain-superfamily and is an important mediator of adaptive
immunity (Jakoš et al., 2019). Cat S is mainly expressed in
immune cells such as B cells, macrophages and dendritic cells
(DCs) and to a lesser extent in some epithelial cells (Gupta et al.,
2008). Unlike most cysteine cathepsins, Cat S shows activity over
a broad pH range which aids in extracellular activity (Gupta et al.,
2008). Cat S is responsible for extracellular matrix (ECM)
breakdown, e.g., elastin, fibronectin, collagen I, II and IV, and
cleavage of cell adhesion molecules, such as JAM-B, ALCAM and
L1CAM among many others (Fonović and Turk, 2014; Sevenich
et al., 2014; Sobotič et al., 2015). This assists immune cell motility
and function, however Cat S overexpression by tumor and
tumor-associated cells, in turn facilitates tumor growth,
invasion and metastasis that can even surpass the blood brain
barrier (Wang et al., 2006; Sevenich et al., 2014). Inhibition of
these processes by small molecule inhibitors reduces cancer
malignancy and improves survival in mouse models (Sevenich
et al., 2014; Olson and Joyce, 2015; McDowell et al., 2020).
Besides taking part in immune cell motility and the processing
of antigenic material (Driessen et al., 1999; Shen et al., 2004),
one of the unique roles of Cat S in immunology is the processing
of the invariant chain (Ii) during the maturation of major
histocompatibility complex II (MHC II), a central step in class
II antigen presentation (Driessen et al., 1999; Bania et al., 2003).
This increases DC motility in a myosin II-dependent manner
which allows DCs to migrate toward the lymph node (Faure-
André et al., 2008). During this process, Cat S specifically
mediates the cleavage of a 10-kDa Ii fragment (Ii p10), which
removes the endoplasmic reticulum retention signal (Theron
et al., 2017). Cat S is essential for this process and specific
inhibition leads to accumulation of MHC II-li p10 complexes
in DCs and B cells (Theron et al., 2017). The li p10 cleavage
leavesmulticolor a heterogeneous set of class II-associated
invariant chain peptides (CLIPs) at the peptide binding groove
of MHC II until exchanged with high affinity antigenic peptides
by the action of human leukocyte antigen DM (HLA-DM).
Together, this enables the presentation of extracellular derived
antigens to CD4+ T helper cells. This process is regulated by TLR
activation and cytokine signaling, where proinflammatory
signals, such as lipopolysaccharides, interleukin 1β, tumor
necrosis factor α and interferons type I and II, promote Cat S
activity resulting in increased MHC II dimerization and CD4+
T cell priming. On the contrary, anti-inflammatory signaling by
IL10 counteracts this process (Fiebiger et al., 2001; Reich et al.,
2007; Jakoš et al., 2019). The role of Cat S in T cell activation has
also linked Cat S to the mechanism of neuropathic pain (Eckert
et al., 2020), and Cat S cleavage of PAR2 causes TRPV4-
dependent inflammatory pain (Zhao et al., 2014). Lastly, Cat S
is an promising therapeutic target for the treatment of
rheumatoid arthritis, psoriasis, asthma, and potentially cystic
fibrosis and COPD (with several molecules at diverse stages of
development) (Wilkinson et al., 2015; Brown et al., 2020).
To gain better understanding of the multifaceted biology of
Cat S several research groups have developed imaging tools to
detect Cat S activity. Since cathepsin activity is highly
regulated, dependent on localization, proteolytic activation
and endogenous inhibitors, standard biochemical techniques
as genetic ablation, the assessment of RNA or protein levels,
fail to outline when and where these proteases are active. An
excellent method to detect proteolytic activity is the use of
activity-based probes (ABPs). ABPs enable the enrichment or
visualization of protease activity in a spatiotemporal fashion
in vitro up to whole organisms (Sanman and Bogyo, 2014). An
ABP typically consists of three parts, the most distinctive being
the electrophilic trap, which is designed to react with the
active-site nucleophile, covalently linking the probe to the
enzyme. This ‘warhead’ is tethered to a recognition or
linker element which can be designed to dictate target
specificity of the ABP. Thirdly, a reporter tag is attached to
facilitate detection. This tag can be a fluorophore, an affinity
tag or a bio-orthogonal functional group, such as an alkyne or
an azide. The latter tags are attractive because of their small
size and flexibility in terms of conjugation of a variety of
reporter tags in a second step after proteome labeling. Such
probes are hence dubbed two-step ABPs.
Using DCG-0N (Greenbaum et al., 2000), a biotinylated
ABP based on the natural product epoxysuccinyl E64, Reich
et al. showed that endocytic uptake via macropinocytosis by
human monocyte-derived dendritic cells (moDCs) routed
peptide-size material selectively to active Cat S (Reich et al.,
2007). DCG-0N in complex with streptavidin however,
resulted in less strict targeting of Cat S and additionally
labeled Cat B and X in moDCs. Lastly, conjugation of
DCG-0N to a cell penetrating peptide abolished the
labeling selectivity completely. This suggests differential
compartmentalization of cathepsin activity, which could be
regulated by phago/endosomal routing and maturation,
directed by factors like specific receptor-mediated uptake or
the size and molecular nature of the engulfed material. Bender
and co-workers developed a selective Cat S quenched ABP
(qABP) for live cell imaging and non-invasive in vivo
applications (Oresic Bender et al., 2015). This helped define
Cat S activity in an orthotopic mouse model of breast cancer
and was able to selectively label Cat S in various tissues.
Contrary to bone marrow-derived macrophages, dual color
cathepsin activity labeling experiments in naïve mouse bone
marrow-derived dendritic cells (BMDCs) revealed vesicles in
which exclusively Cat S activity could be detected, without
labeling of Cat X, B and L activity. The exact structure and
function of these Cat S vesicles remain elusive. Van Elsland
and co-workers recently reported on the combination of bio-
orthogonal labeling with high-resolution correlative light-
electron microscopy (CLEM) to detect activity of cysteine
cathepsins in mouse BMDCs with the pan-reactive two-step
ABP DCG-04-azide (Elsland et al., 2015). As expected,
cathepsin labeling was fully contained within membrane-
limited structures and partly overlapped with LAMP1
lysosomal staining. Here we set out to develop a highly
selective two-step ABP to pinpoint the activity of Cat S
using multicolor bio-orthogonal confocal microscopy
and CLEM.
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MATERIALS AND METHODS
ABP Synthesis
Compounds 2–5 were synthesized as depicted in Schemes 1–3.
Detailed experimental procedures and analytical data can be
found in the Supplemental Material.
Cell Culture
RAW cells (264.7) were maintained in DMEM (Gibco®)
containing high glucose, stable glutamine (GlutaMAX™),
sodium pyruvate and phenol red, which was supplemented
with 10% fetal calf serum (FCS, Bio-Greiner One) and
antibiotics (100 units/ml penicillin, 100 μg/ml streptomycin,
and 250 ng/ml amphotericin B (Gibco®)). The cells were
cultured in a humidified 5% CO2-atmosphere at 37°C and the
culture was passaged every 2–3 days. The cells were suspended via
a cell-scraper, or by incubation with 10 mM EDTA for 5 min at
37°C, followed by centrifugation at 1,000 × g for 5 min at 4°C. The
mediumwas refreshed and the cells were seeded to the appropriate
confluence. Cells were harvested at 80–90% confluence.
Mouse bone marrow was isolated from the femur and tibia
from 8–12 weeks old C57BL/6 mice. Bone marrow-derived
dendritic cells (BMDCs) were obtained by differentiation under
influence of recombinant mouse granulocyte macrophage colony
stimulating factor (GM-CSF) (25 ng/ml) in RPMI medium
containing HEPES, stable glutamine and phenol red, which was
supplemented with fetal bovine calve serum (FCS) (10%), ß-
mercaptoethanol (50 µM) and antibiotics (100 units/ml
penicillin, 100 μg/ml streptomycin, and 250 ng/ml amphotericin
B (Gibco®)). The cells were cultured in a humidified 5% CO2-
atmosphere at 37°C and themediumwas supplemented every three
days with GM-CSF (25 ng/ml, final concentration). The floating
population was harvested after 7 days.
cABPP in Whole Cells
RAW macrophages (2·105 cells in 100 µL conditioned medium)
were incubated with the indicated concentration of inhibitor (200x
in DMSO) for 1 h at 37°C, followed by labeling with 1 µM BMV109
(200x in DMSO) for 1 h at 37°C. The cells were centrifuged at
10,000 × g for 1min at r.t., the supernatant was removed, and the
cells were taken up in 9 µL hypotonic lysis buffer (50mM PIPES pH
7.4, 10 mM KCl, 5 mM MgCl, 4 mM DTT, 2mM EDTA, and 1%
NP40). The lysate was incubated on ice for 5 min, followed by
centrifugation at 21,130x g for 15 min at 4°C. The cleared lysate was
diluted with 3 µL Laemmli’s 4x sample buffer (40% glycerol, Tris/
HCl (0.2 M, pH 6.8), 8% SDS, 10% BME, and 0.04% bromophenol
blue) and the mixture was denatured over 5 min at 95°C. The
samples were spun down and separated by SDS PAGE (15%,
15 min at 80 V, 1.5–2 h at 120 V). The gel was analyzed by in-gel
fluorescence scanning on a Typhoon Trio flat-bed laser scanner (GE
Healthcare) and equal protein loading was confirmed by staining
with Coomassie® Brilliant Blue R-250 (Schmidt GmbH).
Copper-Click cABPP in Whole Cells
Intact RAWs or BMDCs (some 2·105 cells in 100 µL conditioned
culture medium) were incubated with the indicated
concentration of inhibitor (200x in DMSO) for 1 h at 37°C,
prior to labeling with 1 µM BMV109 (200x in DMSO) for 1 h
at 37°C. The cells were centrifuged (10,000x g for 1 min at r. t.),
the supernatant was removed, and the cells were taken up in 10 µL
lysis buffer (50 mM HEPES pH 7.3, 10 mM KCl, 5 mM MgCl2
and 1% NP40). The lysate was incubated on ice for 15 min
followed by centrifugation at 21,130 × g for 15 min at 4°C. The
conditioned lysate was incubated with 10 µL click-cocktail
(50 mM HEPES pH 7.3, 1 mM CuSO4, 10 mM sodium
ascorbate, 1 mM THPTA ligand, 10 mM amino-guanidine,
5 μM AF488 alkyne (Click Chemistry Tools)) for 1 h at 20°C.
The protein was pelleted by addition of 80 µL cold acetone
followed by incubation at −20°C for 30 min. The lysate was
centrifuged (21,130 × g for 15 min at 4°C), the supernatant
was removed and the samples were taken up in 15 µL
Laemmli’s 1x sample buffer (10% glycerol, 50 mM Tris/HCl
pH 6.8, 2% SDS, 2.5% BME, and 0.01% bromophenol blue),
denatured for 5 min at 95°C and separated by SDS PAGE (15%).
The gel was analyzed by in-gel fluorescence scanning on a
Typhoon Trio (GE Healthcare) flat-bed laser scanner and
equal protein loading was confirmed by staining with
Coomassie® Brilliant Blue R-250 (Schmidt GmbH).
cABPP-labelling intensities were quantified using ImageJ
software (Schneider et al., 2012). Data was transferred to
Microsoft Excel, corrected for background fluorescence, and
scaled to the positive control (DMSO, BMV109) as 100%-
activity reference point. The mean, standard deviation (SD),
and standard error of the mean (SEM) were calculated and
normalized to the corrected positive control. The data was
transferred to Graphpad Prism 6.0 and IC50-values were
calculated using non-linear regression.
Confocal Microscopy
BMDCs were seeded (2·105) on an 8-well chamber slide (Ibidi)
and left to grow for 2 h. Next E. coli B834-cells harboring Hpg
were added to the cells in a 50:1 ratio. After 1 h, the cells were
washed three times with PBS, and fresh medium was added. The
cells were incubated with 100 nM probe 5 (200x in DMSO) for 1 h
after which the cells were washed three times with PBS, then
incubated with 1 µM BMV109 (200x in DMSO) for 1 h and
washed again. The cells were fixed in 4% PFA for 2 h and
until further analysis cells were kept in 0.5% PFA in PBS at
4°C. When all slides were collected, fixed cells were washed
with PBS and PBS containing 20 mM glycine (PBS/glycine).
Membrane permeabilization was achieved by incubating with
0.1% Triton-X100 for 20 min, followed by a PBS wash. Dual
copper-catalyzed Huisgen cycloaddition (ccHc) reaction was
performed sequentially with intermediate PBS washes as
described previously (Bakkum et al., 2020), with click cocktail
1 ((0.1 M HEPES, pH 7.3, 1 mM CuSO4, 10 mM sodium
ascorbate, 1 mM THPTA ligand, 10 mM amino-guanidine,
5 µM AFDye555-azide (Click Chemistry Tools)) for 30 min to
label Hpg-E. coli, followed by click cocktail 2 ((0.1 M HEPES, pH
7.3, 1 mM CuSO4, 10 mM sodium ascorbate, 1 mM THPTA
ligand, 10 mM amino-guanidine, 5 µM AF488-alkyne (Thermo
Fisher)) for 30 min to label Cat S. Cells were washed with PBS and
blocked with PBS containing 1% BSA for 30 min to assist in
removing non-specifically bound fluorophores. After two more
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PBS washes, the nuclei were counterstained with 2 μg/ml Hoechst
33342 for 5 min and washed once more with PBS, prior to
imaging in glycerol/DABCO solution on an Andor Dragonfly
505 Spinning Disk Confocal (Oxford Instruments), containing an
8-line integrated laser engine. Images were acquired with the Zyla
2048 × 2048 sCMOS camera and 2 × 2 camera binning controlled
with the integrated Fusion software. Z-series optical sections were
collected with a system-optimized step-size of 0.13 microns and
were deconvolved using the integrated ClearView-GPU™
deconvolution software. Z-series are displayed as maximum
z-projections, and gamma, brightness and contrast were
carefully adjusted (identically for compared image sets) using
FIJI (Schindelin et al., 2012).
B-CLEM–Sample Preparation
The sample preparation for bio-orthogonal correlative light-
electron microscopy (B-CLEM) and bio-orthogonal labeling
was performed as previously described (Bakkum et al., 2020).
Briefly, following infection and post-infection incubation with the
cathepsin probes, BMDCs were washed three times with
conditioned medium and once with PBS. The cells were fixed
with TEM-optimized fixation solution (2% EM-grade
paraformaldehyde, 0.2% EM-grade glutaraldehyde in 0.1 M
phosphate buffer pH 7.2; Electron Microscopy Sciences) for
2 h at r. t., washed with PBS and stored in storage buffer
(0.5% EM-grade paraformaldehyde in 0.1 M phosphate buffer
pH 7.2) at 4°C until all time points were collected. Fixed cells were
rinsed with PBS and PBS/glycine, harvested in warm 1% gelatin
(type A, bloom 300; Sigma-Aldrich) in PBS via cell scraper and
transferred to a 15 ml Falcon tube, prior to collection by
centrifugation. The pellet was suspended in warm 1% gelatin
in PBS (100 µL), transferred to a 1.5 ml Eppendorf tube. Warm
12% gelatin in PBS was added (1 ml) and the cells were pelleted by
centrifugation (3 min at 800 × g). The pellets were jellified on ice
and the sample pellet was cut off from the tube and cut in half
with a surgical blade. Sample cubes of approx. 1 mm2 were
prepared and rotated in a 2.3 M sucrose solution for 18 h to
allow for sucrose infiltration. This was followed by plunge-
freezing the cubes on metal support pins.
B-CLEM–Cryo-Sectioning and on Section
staining
Ultrathin (75 nm) cryo-sections were prepared according to
the Tokuyasu technique (Tokuyasu, 1973), using a Leica UC7
Ultramicrotome equipped with Leica EM FC7 Cryochamber and
Leica EM Crion ionizer/charger, Diatome Micromanipulator,
Diatome Trim 20° knife and a Diatome Cryo Immuno 35°
knife.. After collection, the sections were thawed on a droplet
of pickup fluid (1.15 M sucrose, 1% methylcellulose) and
transferred to a Formvar/carbon-coated TEM grid (titanium,
100 square mesh, 3.05 mm, center-marked; Agar Scientific),
pre-coated with blue 0.2 µm FluoSpheres (Thermo Fisher) as
fiducial markers. These on-grid cryo-sections were incubated on
droplets of 2% gelatin in PBS for 30 min at 37°C, followed by
washing 5 times on PBS/glycine. The subsequent dual ccHc
reactions were performed as described above, followed by
three washes with PBS. The sections were then incubated on
FIGURE 1 | Structures of the reported Cat S selective inhibitor LHVS (1) and the first and second generation LHVS-derived two-step ABPs.
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droplets of 1% BSA in PBS for 3 × 10 min at r. t., to assist the
removal of non-specifically bound fluorophores. Sections were
additionally blocked on 0.1% BSA-c (Aurion) in PBS before
incubating 1 h on anti-MHC II (M5/114, 1:300, BioXCell) or
anti-LAMP-1 (1D4B, 1:300, eBioscience) in 0.1% BSA-c, followed
by 20 min on a rabbit-anti-rat (1:50, Abcam) bridging antibody,
and 20 min on protein-A conjugated to 15 nm gold (1:50;
Aurion), with intermediate washes on 0.1% BSA-c. Sections
were subsequently washed three times on PBS and antibody
complexes immobilized by incubating 5 min on 1%
glutaraldehyde, followed by additional PBS washes. Nuclear
staining of the host cells was achieved by incubating the




After several washes with PBS, the fluorescently labelled sections
on TEM grids were mounted in water containing 30% glycerol
between a microscopy slide and a coverslip, and imaged by
confocal microscopy as described above. The TEM grids
containing the sections were recovered, rinsed in distilled
water, and incubated for 5 min on droplets of uranyl acetate/
methylcellulose. These sections were then imaged on a FEI Tecnai
12 BioTwin TEM System (FEI Technologies) at 120 kV
acceleration voltage. Correlation of FM and TEM images was
performed in Adobe Photoshop CC 2020 (Adobe Systems) as
described previously (Bakkum et al., 2020).
RESULTS
Synthesis of First Generation LHVS-Derived
Two-step ABPs
Morpholine leucine homophenyl vinyl sulfone (LHVS) (1,
Figure 1) was selected as a starting point for the development
of a two-step ABP. LHVS has been reported as a highly selective,
nanomolar potent inhibitor of Cat S with near diffusion-limited
kinetics (Palmer et al., 1995). Because vinylsulfones are effectively
SCHEME 1 | Synthesis of LHVS derivative 2 (FD054). Reagents and conditions: (A)NaH, THF, 0°C, 15min, then diethyl (iodomethyl)phosphonate, THF, 0°C to r. t.,
72 h, quant.; (B) i. bromoacetyl bromide, DiPEA, DCM, 0°C, 1 h ii. NaN3, DMF, r. t., 4 h, quant.; (C) AcOOH, DCM, 0°C to r. t., 4 h, 93%; (D) DMHA·HCl, HBTU, DiPEA,
DMF, r. t., 1 h, quant.; (E) LiAlH4, THF, 0°C, 15min, 94%; (F) phosphonate 3, NaH, THF, -10°C, 15min, then aldehyde 12, THF, -10°C to r. t., 16 h, 42%; (G) i. TFA/DCM,
r. t., 30 min, ii. Boc-l-Leu-OSu, DiPEA, DMF, r. t., 4 h, 95%; (H) i. morpholine, DiPEA, triphosgene, THF, 0°C, ii. carbamate 7, TFA/DCM, r. t., 30 min, iii. crude
carbonyl chloride, DiPEA, DMAP (cat.), THF, r. t., 16 h, 32%.
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inert in the absence of an enzyme’s catalytic machinery, they
represent an excellent class of electrophilic traps to facilitate
selective labeling (Palmer et al., 1995). In a first attempt to
synthesize LHVS-derived two-step ABPs two target molecules
were designed, in which an azide handle was introduced to
facilitate click chemistry (Kolb et al., 2001), either by
extending the molecule on the phenyl vinylsulfone or in the
P2 position, resulting in compounds 2 and 3, respectively
(Figure 1).
LHVS derivative 2was synthesized using amodified procedure of
the vinylsulfone synthesis described by Van der Linden and
colleagues (van der Linden et al., 2015). In short, 4-
aminothiophenol 6 was substituted with diethyl (iodomethyl)
phosphonate 7 yielding thioether 8 (Scheme 1). Condensation
with bromoacetyl bromide followed by substitution with sodium
azide yielded azide 9 and subsequent oxidation with peracetic acid
yielded phosphonate 10. Boc-L-homophenylalanine was converted
into its corresponding aldehyde 12 by reduction of the Weinreb
amide with lithium aluminum hydride and subsequent Horner-
Wadsworth-Emmons (HWE) olefination with phosphonate 10
furnished vinylsulfone 13. Boc-deprotection followed by
condensation with Boc-L-Leu-OSu and subsequent Boc-
deprotection and coupling with morpholine carbonyl chloride
yielded LHVS derivative 2 (FD054). Similarly, thiophenol 15 was
substituted with phosphonate 7 followed by oxidation with peracetic
acid to form 17 (Scheme 2). HWE olefination with aldehyde 11
yielded vinyl sulfone 20 and sequential Boc-deprotections, and
subsequent coupling with Boc-L-Aza-OSu 19 and morpholine
carbonyl chloride, respectively, afforded compound 3 (FD062).
In vitro Performance of the First Generation
LHVS-Derived Two-step ABPs
To investigate the inhibition efficiency of the synthesized LHVS
derivatives a competitive activity-based protein profiling
(cABPP) assay was performed in 264.7 RAW cells (a mouse
macrophage cell line). Live RAW cells were incubated with
increasing concentrations of LHVS (1), 2 and 3, after which
residual cathepsin activity was labeled with pan-reactive qABP
BMV109 (Verdoes et al., 2013). Cells were lyzed and the
proteome was separated by SDS-PAGE. Next, in-gel
fluorescence scanning and quantification of the decrease in
labeling intensity yielded the apparent half-maximal inhibitory
concentrations (IC50s) (Figure 2). Unexpectedly, this revealed
that LHVS has significant off-target activity against Cat L, in
addition to its nanomolar inhibition of Cat S. Apparently, the
reported inhibitory constants (Ki) and potencies (Kinact/Ki)
(Palmer et al., 1995) fail to reflect the eventual inhibitory
potency and selectivity in a whole cell setting. Introduction
of an azide tag on the phenyl vinylsulfone in probe two resulted
in some 40-fold decrease in potency for Cat S, while cross-
reactivity with Cat L was maintained and the selectivity
window with Cat B was decreased. Coincidently, cABPP
revealed that the replacement of the P2 leucine of LHVS
with azidoalanine in compound 3 increased the selectivity
window, leading to some 40-fold selectivity for Cat S in
respect to Cat L, albeit at the cost of a slight (some 4-fold)
reduction in potency toward Cat S. Unfortunately,
subsequent two-step labeling experiments showed that
SCHEME 2 | Synthesis of LHVS derivative 3 (FD062). Reagents and conditions: (A)NaH, THF, 0°C, 15min, then diethyl (iodomethyl)phosphonate, THF, 0°C to r. t.,
2 h, quant.; (B) AcOOH, DCM, 0°C to r. t., 4 h, 95%; (C) imidazole-1-sulfonyl azide, K2CO3, CuSO4·5H2O (cat.), MeOH, r. t., 16 h, 71%, (D) LiAlH4, THF, 0°C, 15 min,
89%; (E) phosphonate, NaH, THF, -10°C, 15 min, then crude aldehyde 12, THF, -10°C to r. t., 3 h, 70%; (F) i. TFA/DCM, r. t., 30 min, ii. Boc-L-Aza-OH, HBTU, DiPEA,
DMF, r. t., 16 h, quant.; (G) i. TFA/DCM, r. t., 30 min, ii. 4-morpholine carbonyl chloride, DiPEA, DMF, r. t., 16 h, 31%.
Frontiers in Chemistry | www.frontiersin.org February 2021 | Volume 8 | Article 6284336
van Dalen et al. Selective Cathepsin S Two-Step Activity-Based Probe
compound 3 in complex with Cat S was unable to be labeled
with Alexa Fluor 488 (AF488) alkyne (Figure 3A). That while
probe 2 showed a concentration-dependent increase in AF488
fluorescence intensity, correlating with the decrease in Cy5
fluorescence due to the competition with BMV109 labeling
(Figure 3A). Even upon harsh denaturing conditions Cat S
modified with 3 could not be labeled with AF488 alkyne (results
not shown).
To gain further insight in the difference between LHVS and 3
with respect to binding interactions with Cat S and L, a docking
FIGURE 3 | Dual color competitive labeling (A) (B)Whole RAW cells were incubated with indicated concentration of inhibitor/probe for 1 h and residual cathepsin
activity was labeled with BMV109 (blue) over 1 h. Cells were lyzed and the proteomes were labeled with AF488-alkyne (green) using copper-catalyzed click chemistry (C)
Mouse bonemarrow-derived dendritic cells were incubated with the indicated concentration of inhibitor followed by labeling with BMV109 (blue) and click chemistry with
AF488-alkyne (green). IC50s were determined by analysis of the competitive labeling by BMV109 and are given in nanomolar. The fold-selectivity for Cat S is
calculated from the apparent IC50s. Experiments were performed in duplicate. FJD164 (Supplementary Scheme S1) was used as positive control (PC) for click
labeling.
FIGURE 2 | Competitive labeling of LHVS derivatives. Live RAW macrophages were incubated with the indicated concentration of inhibitor for 1 h after which the
residual cathepsin activity was labeled with BMV109. The cells were lyzed, separated by SDSPAGE and the labeling intensity was quantified. IC50s and selectivity for Cat
S were calculated and are presented in the adjacent table. Experiments were performed in duplicate.
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study was performed based on the reported crystal structure of
LHVS in complex with Cat S (Pauly et al., 2003). From this crystal
structure three residues can be defined in the S2 pocket that are
unique to Cat S, which might confer specificity in respect to Cat L
(Supplemental Figure S1 and Figure 4). The entrance of the S2
site is governed by a ß-branched valine 162, which makes the
entry of the S2 pocket narrower in Cat S in comparison with Cat L
where methionine 161 is found in this position (Figure 4). This
open S2 structure of Cat L likely facilitates the cross-reactivity of
the P2 leucine toward Cat L. Secondly, the S2 subsite in Cat S is
more plastic, governed by phenylalanine 211 which can fold away
to accept bulky substituents (Pauly et al., 2003). In Cat L a
completely open structure is provided by an alanine 214
residue, which confers limited options for selectivity between
the two enzymes. Lastly, the S2 pocket in Cat S is deeper where
extra space is governed by glycine 137 in comparison with alanine
135 in Cat L. Specifically this alanine distorts the docking of the
P2 azide in Cat L (Figure 4). This subsequently disrupts the
binding of the S3 morpholine in the P3 pocket. We hypothesize
that the slight reduction in potency toward Cat S might follow
from the loss of Van Der Waals interactions between the
hydrophobic S2 pocket and the P2 azidoalanine in compound
3 relative to the leucine in LHVS. Together, this could help
explain the improved selectivity for Cat S of compound 3 as
observed in the cABPP experiment.
Synthesis of the Second Generation
LHVS-Derived Two-step ABPs
The observed Cat S selectivity of compound 3 encouraged the
design of a second generation LHVS-derived two-step ABPs in
which a solvent-exposed azide was introduced to enable efficient
bio-orthogonal labeling. Extension of the P1 homophenylalanine
of LHVS and inhibitor 3 with an azidoethyl ether results in target
compounds 4 and 5, respectively (Figure 1). Synthesis
commenced from Boc-L-homotyrosine 22 to facilitate the
incorporation of an azide group on the phenyl ring (Scheme
3). In order to mitigate reduction of the azide group during
preparation of the required aldehyde, an alternative to the
Weinreb-amide route was designed based on Swern oxidation
of the corresponding alcohol.
Boc-L-homotyrosine was reduced with borane in THF and
global protection with tert-butyldimethylsilyl chloride followed
by regio-selective deprotection of the phenolic silyl ether with
tetra-n-butylammonium fluoride (TBAF) furnished phenol 24. 2-
Bromoethanol was reacted with sodium azide and subsequently
with 4-toluenesulfonyl chloride to form 2-azidoethyl tosylate 25,
which was reacted with phenol 24 to yield azide 26. Next,
deprotection with TBAF gave alcohol 27, which was oxidized
to the aldehyde via Swern oxidation, followed by HWE
olefination with phosphonate 17 to produce vinylsulfone 28.
Next, probe 4 (FJD237) was obtained by subsequent Boc-
deprotection, coupling with Boc-L-leucine-OSu followed with
Boc-removal and coupling with morpholine carbonyl chloride.
Similarly, sequential Boc-deprotections and coupling with Boc-
L-azidoalanine-OSu and morpholine carbonyl chloride,
respectively, yielded probe 5 (FJD239).
Dual Color cABPP With Second Generation
LHVS-Derived Two-step ABPs
With the synthesized second generation probes in hand, a dual
color two-step labeling cABPP experiment was performed in
RAW macrophages (Figure 3B). After incubation with live cells
and subsequent cell lysis, the labeled proteomes were subjected to
copper-catalyzed click chemistry with AF488 alkyne to visualize
FIGURE 4 | Molecular docking of LHVS analogues in cathepsin S and L. Molecular docking of LHVS (gray) and 3 (purple) in cathepsin S reveals a near identical
binding mode for both inhibitors. Whereas docking overlay of LHVS (gray) and 3 (green) in cathepsin L reveals a significant clash between the azide group and Ala135 in
cathepsin L distorting the binding mode. Molecular docking and image preparation was performed with MOE molecular dynamics software.
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the formed probe-cathepsin conjugates. Compared to LHVS, the
introduction of the azidoethyl ether in probe 4 did not majorly
effect the inhibitory potency. Robust two-step labeling of Cat B, S
and L was detected in the AF488 channel. Cat X was unaffected
at the concentrations used. Di-azido-probe 5 showed an
inhibition profile similar to inhibitor 3, with a good
apparent selectivity window for Cat S, albeit slightly less
potent and selective, possibly as a consequence of the
introduction of the azidoethyl ether in P1. As seen for
probe 4, two-step labeling of probe 5 was robust, with a
good window for selective Cat S labeling between 10 and
100 nM. Next, probe 5 was tested in naïve mouse BMDCs
to investigate the selectivity for Cat S in this cell type
(Figure 3C). BMDCs have an increased relative expression
of Cat S, which in turn increased the selectivity of the labeling
to over 50-fold. Saturated labeling can be observed at a
concentration of 100 nM without any off-target labeling in
BMDCs. This shows that probe 5 allows selective saturation
and labeling of Cat S activity.
Multicolor Bio-Orthogonal Confocal
Microscopy and Correlative Light-Electron
Microscopy
To address whether probe 5 would be applicable to image cellular
localization of Cat S activity via bio-orthogonal conjugation of a
fluorescent dye, we performed a set of pilot confocal microscopy
experiments with mouse BMDCs which were treated with probe
five and the broad-spectrumprobe BMV109 sequentially (Figure 5A).
Furthermore, BMDCs were given homopropargylglycine labeled
E. coli (Hpg-E. coli) for 3 h prior to labeling with the
aforementioned ABP-cocktail (Figure 5B). This would allow
us to assess whether probe 5 could also be imaged in a ‘dual-
click’ approach with the potential to determine the distribution
SCHEME 3 | Synthesis of LHVS derivative 4 (FJD237) and 5 (FJD239). Reagents and conditions: (A) borane, THF, 0°C, 5 h, quant.; (B) i. TBDMSCl, imidazole,
DMF, r. t., 30 min, ii. TBAF, THF, 0°C, 1 h, quant.; (C) NaH, DMF, -10°C to r. t., 1 h, 95%; (D) TBAF, THF 0°C, 15 min, 98%; (E) i. Oxalyl chloride, DMSO, Et3N, DCM,
-78°C to r. t., 30 min, ii. NaH, THF, then crude aldehyde, -10°C to r. t., 30 min, 90%; (F) i. TFA/DCM, 30 min, r. t., ii. Boc-L-Leu-OSu, DiPEA, DMF, 16 h, r. t., 93%; (G) i.
TFA/DCM, 30min r. t., ii. morpholine carbonyl chloride, DiPEA, DMF, 16 h, r. t., 55%; (H) i. TFA/DCM, 30min, r. t., ii. Boc-L-Aza-OSu, DiPEA, DMF, 16 h, r. t., 77%;
(I) i. TFA/DCM, 30 min, r. t., ii. morpholine carbonyl chloride, DiPEA, DMF, 16 h, r. t., 51%.
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of Cat S activity in response to, and relative to this bacterial
stimulus (Bakkum et al., 2020). We noted a high variance in
cathepsin activity between BMDCs, which might follow from
the fact that GM-CSF-generated BMDCs form a highly
heterogeneous population of monocytic cells (Helft et al.,
2015). We also noted that, intact bacteria can still be
observed at 3 h post infection, and within this timeframe no
specific redistribution of either probe 5 or BMV109 to whole E.
coli-containing vesicles could be observed. Furthermore, we
observed that most vesicles labeled positive for both Cat S
activity and the pan-reactive probe BMV109. Some vesicles
can be observed that exclusively contain Cat S activity
without detectable activity of Cat X, B and L (Figure 5,
white arrows), which is in line with the observation of
Bender and co-workers (Oresic Bender et al., 2015).
Nonetheless, the exact function and nature of these vesicles
remain elusive.
To assess the feasibility of providing ultrastructural context
to Cat S labeling, a pilot bio-orthogonal CLEM (B-CLEM)
experiment was performed (Elsland et al., 2015). In this
experiment, 75 nm sections of the BMDCs exposed to Hpg-
E. Coli were taken after incubation with 5 and BMV109,
followed by on-section sequential click reactions to
fluorescently label bacterial products and probe 5 in
complex with Cat S. Furthermore, MHC II was labeled with
15 nm gold particles to be imaged in negative stain
transmission electron microscopy. After correlation of the
two images, the fluorescence signals could be assessed in
FIGURE 5 | Dual click labeling in confocal microscopy (A) Naïve BMDCs (at time point 0) were treated subsequently with probe 5 (green) for 1 h and BMV109 (red)
for 1 h, and probe 5 was visualized through click chemistry (B) BMDCs were treated with Hpg-labelled E. coli (white) for 3 h followed by probe 5 (green) and BMV109
(red) labeling ensued by tandem click chemistry. Specialized Cat S vesicles are annotated with white arrows. Scale bar represents 5 µm.
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their ultrastructural context (Figure 6). Although no
biological conclusions can be drawn from this pilot
feasibility study, it does illustrate the potential of four color,
dual bio-orthogonal fluorescence imaging in combination with
CLEM and immunogold labeling. In the example shown,
apparent colocalization between Cat S activity, bacterial
digests and MHC II immunogold labeling seems to occur
(Figure 6, arrow 1). Also vesicles costained for MHC II and
Cat S with negligible BMV109 labeling are visible ((Figure 6,
arrow 2), as well as vesicles seemingly containing solely Cat S
activity (Figure 6, arrow 3). Together, this exemplifies the
great applicability of probe five in fluorescence microscopy and
state-of-the-art dual B-CLEM.
DISCUSSION
Cat S is an important mediator of adaptive immunity and an
attractive pharmaceutical target in for example cancer and
inflammatory pain. To pinpoint Cat S activity relative to other
cysteine proteases in microscopy experiments, there is a challenge
of generating highly selective ABPs. In this work the development
and application of a highly Cat S selective two-step ABP is
presented. As a starting point for our probe design we chose
the small molecule inhibitor LHVS, which has been reported and
extensively applied as a selective inhibitor of Cat S. Of note, the
selectivity of in particular irreversible inhibitors and probes is
highly dependent on experimental conditions and the relative
activity of potential off-targets. Based on the results in this study,
the major difference in inhibitory constants (Ki) and potencies
(Kinact/Ki) as reported for recombinant Cat S and Cat L in vitro
(120-fold selectivity) (Palmer et al., 1995), failed to adequately
reflect the eventual inhibition selectivity in live RAW cells (2-fold
selectivity) (Figure 2). To us, this emphasizes the vital importance
of testing new potential selective compounds in a more complex
setting such as live cells and validate the target engagement and
on-target selectivity through for example cABPP with broad-
spectrum ABPs. Coincidently, a first attempt to obtain an LHVS-
derived two-step ABP by replacement of the P2 leucine with
azidoalanine resulted in a highly selective Cat S inhibitor.
However, positioning of the azide ligation handle in the S2
pocket renders compound 3 resistant to copper catalyzed azide
alkyne cycloaddition, even after denaturation of the irreversibly
inhibited enzymes. Hence, in order to accomplish selective
labeling two azides had to be incorporated on the LHVS
structure. This yielded the highly selective and potent two-step
ABP 5 for Cat S.
A set of pilot feasibility experiment demonstrated that this
probe could be readily applied to image the localization of Cat
S activity in BMDCs, both by using conventional confocal
microscopy as well as CLEM. These experiments highlight the
applicability and potential of probe five in multi-color
confocal microscopy and bio-orthogonal CLEM. Therefore,
the probe developed in this study could be applied in
delineating the role of active Cat S in the fields of cancer,
autoimmune disorders, bacterial pathogenesis and
inflammatory pain.
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